Search on: COSMEGEN LYOVAC 
Descriptors Found: 1
Displaying: 1 .. 1  

 1 / 1 DeCS     
Descriptor English:   Dactinomycin 
Descriptor Spanish:   Dactinomicina 
Descriptor Portuguese:   Dactinomicina 
Synonyms English:   Ac-De
Cosmegen
Cosmegen Lyovac
Lemery Brand of Dactinomycin
Lyovac-Cosmegen
MSD Brand of Dactinomycin
Merck Brand of Dactinomycin
Merck Frosst Brand of Dactinomycin
Merck Sharp & Dohme Brand of Dactinomycin
Lyovac, Cosmegen
Actinomycin D
Meractinomycin
Actinomycin  
Tree Number:   D03.633.300.200
D04.345.566.252
D12.644.641.252
Definition English:   A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) 
Pharmacological Action:   Anti-Bacterial Agents
Antibiotics, Antineoplastic
Nucleic Acid Synthesis Inhibitors
Protein Synthesis Inhibitors
 
History Note English:   66; ACTINOMYCIN was heading 1963-95 
Allowable Qualifiers English:  
AD administration & dosage AE adverse effects
AG agonists AA analogs & derivatives
AN analysis AI antagonists & inhibitors
BI biosynthesis BL blood
CF cerebrospinal fluid CS chemical synthesis
CH chemistry CL classification
CT contraindications EC economics
HI history IM immunology
IP isolation & purification ME metabolism
PK pharmacokinetics PD pharmacology
PO poisoning RE radiation effects
ST standards SD supply & distribution
TU therapeutic use TO toxicity
UR urine  
Record Number:   3628 
Unique Identifier:   D003609 

Occurrence in VHL:
 

Similar:

 
DeCS CID-10 SciELO LILACS LIS